Literature DB >> 27113150

Anticoagulation in Older Adults with Multimorbidity.

Anna L Parks1, Margaret C Fang2.   

Abstract

The number of patients with atrial fibrillation (AF) who are of advanced age or have multiple comorbidities is expected to increase substantially. Older patients with AF generally gain a net benefit from anticoagulation. Guidelines typically recommend anticoagulation. There are multiple challenges in the safe use of anticoagulation in frail patients, including bleeding risk, monitoring and adherence, and polypharmacy. Although there are options for chronic oral anticoagulation, clinicians must understand the unique advantages and disadvantages of these medications when developing a management plan. This article reviews issues surrounding the appropriate use and selection of anticoagulants in complex older patients with AF.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anticoagulation; Atrial fibrillation; Bleeding risk; Multimorbidity; New oral anticoagulants; Polypharmacy; Warfarin

Mesh:

Substances:

Year:  2016        PMID: 27113150     DOI: 10.1016/j.cger.2016.01.003

Source DB:  PubMed          Journal:  Clin Geriatr Med        ISSN: 0749-0690            Impact factor:   3.076


  6 in total

1.  Creatinine Versus Cystatin C: Differing Estimates of Renal Function in Hospitalized Veterans Receiving Anticoagulants.

Authors:  Christina Hao Wang; Anna D Rubinsky; Tracy Minichiello; Michael G Shlipak; Erika Leemann Price
Journal:  J Gen Intern Med       Date:  2018-05-31       Impact factor: 5.128

2.  Labile PT-INR in a Covid-19 Patient Under Long-term Vitamin K Antagonist Therapy: a Case Report.

Authors:  Caterina Trevisan; Lorella Miconi; Emanuele Barbierato; Giuseppe Marinaro; Stefano Targhetta; Mario D'agata; Daniela Rinaldi
Journal:  SN Compr Clin Med       Date:  2020-08-19

3.  Long-term individual and population functional outcomes in older adults with atrial fibrillation.

Authors:  Anna L Parks; Sun Y Jeon; W John Boscardin; Michael A Steinman; Alexander K Smith; Margaret C Fang; Sachin J Shah
Journal:  J Am Geriatr Soc       Date:  2021-03-05       Impact factor: 7.538

4.  Use of Non-Vitamin K Antagonist Oral Anticoagulants Among Patients with Nonvalvular Atrial Fibrillation and Multimorbidity.

Authors:  Steven Deitelzweig; Allison Keshishian; Amiee Kang; Amol D Dhamane; Xuemei Luo; Christian Klem; Lisa Rosenblatt; Jack Mardekian; Jenny Jiang; Huseyin Yuce; Gregory Y H Lip
Journal:  Adv Ther       Date:  2021-05-07       Impact factor: 3.845

5.  Complementing chronic frailty assessment at hospital admission with an electronic frailty index (FI-Laboratory) comprising routine blood test results.

Authors:  Hugh Logan Ellis; Bettina Wan; Michael Yeung; Arshad Rather; Imran Mannan; Catherine Bond; Catherine Harvey; Nadia Raja; Peter Dutey-Magni; Kenneth Rockwood; Daniel Davis; Samuel D Searle
Journal:  CMAJ       Date:  2020-01-06       Impact factor: 8.262

6.  Management of Atrial Fibrillation in Older Patients by Morbidity Burden: Insights From Get With The Guidelines-Atrial Fibrillation.

Authors:  Frederik Dalgaard; Haolin Xu; Roland A Matsouaka; Andrea M Russo; Anne B Curtis; Peter Vibe Rasmussen; Martin H Ruwald; Gregg C Fonarow; Angela Lowenstern; Morten L Hansen; Jannik L Pallisgaard; Karen P Alexander; John H Alexander; Renato D Lopes; Christopher B Granger; William R Lewis; Jonathan P Piccini; Sana M Al-Khatib
Journal:  J Am Heart Assoc       Date:  2020-11-26       Impact factor: 5.501

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.